Biologics Manufacturing
Source: ReciBioPharm
ReciBioPharm GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature state-of-the-art equipment for animal cell-derived viral and microbial products for your clinical trials in phase 1-2 and in accordance with cGMP guidelines.
Flexible partnerships
ReciBioPharm offers flexible business models to meet the needs of your project, including:
- Traditional CDMO, offering pay per batch with multi-product/multi-client suites, using work statements to reserve capacity
- Dedicated capacity for customers with sufficient demand and a need to support supply through licensing. We offer flexible scheduling for multi-product use, ramping up to maximum output with person-in-plant for technical oversight and fixed capacity access fee plus variable costs
- Custom manufacturing partnerships tailored to your programme requirements
Click here to learn more about our Biologics Development services.